Loading: 100%
UNITED THERAPEUTICS Corp logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 750 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker UTHRno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100120140160180
datesClosing price (adj.)
13.10.2017120.51
11.10.2017120.15
04.10.2017122.21
27.09.2017119.46
20.09.2017117.57
13.09.2017123.18
06.09.2017135.03
30.08.2017129.17
23.08.2017130.72
16.08.2017132.04
09.08.2017129.00
02.08.2017127.92
26.07.2017131.40
19.07.2017131.25
12.07.2017129.94
05.07.2017133.86
27.06.2017130.94
20.06.2017130.12
13.06.2017131.15
06.06.2017126.12
30.05.2017118.91
23.05.2017121.46
16.05.2017122.82
09.05.2017124.79
02.05.2017121.23
25.04.2017121.74
18.04.2017121.08
11.04.2017121.78
04.04.2017124.45
28.03.2017141.19
21.03.2017138.28
14.03.2017145.53
07.03.2017144.99
28.02.2017147.72
21.02.2017167.92
14.02.2017165.67
07.02.2017162.82
31.01.2017163.63
24.01.2017156.62
17.01.2017147.94
10.01.2017152.46
03.01.2017143.99
27.12.2016143.53
19.12.2016143.24
12.12.2016138.95
05.12.2016129.37
28.11.2016132.74
21.11.2016131.45
14.11.2016134.35
07.11.2016119.55
31.10.2016120.07
24.10.2016111.80
17.10.2016117.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
120.51n/a
Market Capitalisation
in million USD
5,430n/a
Enterprise Value
in million USD
4,274n/a
Common Shares Outstanding
as per Apr 19, 2017
45,056,932n/a
Preferred Shares Outstanding
as per Apr 19, 2017
n/a
Average Basic Shares Outstanding
TTM
43,575,000n/a
Average Diluted Shares Outstanding
TTM
46,100,000n/a
Index Membership
n/a
Business Summary
United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 1,156n/a
Receivables 188n/a
Total Current Assets 1,504n/a
PP&E 494n/a
Total Assets 2,561n/a
Accounts Payable 106n/a
Current Debt 0n/a
Total Current Liabilities 428n/a
Long-Term Debt 0n/a
Total Liabilities 496n/a
Total Equity 2,065n/a
Cash Flow
Depreciation & Amortisation 32n/a
Change in Working Capital -76n/a
Operating Cash Flow 749n/a
Net Change in PP&E and Intangibles -50n/a
Investing Cash Flow -129n/a
Dividends Paid 0n/a
Financing Cash Flow -340n/a
Total Change in Cash 276n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 47.40n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 2.54n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.38n/a
Other Ratios
Current Ratio 351.7%n/a
Liabilities to Equity Ratio 24.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
281
359
593
743
916
1,117
1,289
1,466
1,599
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-30
-41
-68
-89
-119
-131
-126
-69
-73
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
251
318
525
654
797
986
1,163
1,397
1,526
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-333
-292
-354
-336
-375
-693
-624
-698
-464
Selling, General & Administrative
-94
-172
-189
-156
-202
-394
-381
-453
-317
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-239
-120
-165
-180
-173
-299
-243
-245
-148
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
-82
26
171
318
422
292
539
699
1,062
Non-Operating Income (Loss)
-21
-19
-23
-24
-52
-23
-22
-5
-6
Interest Expense, net
-22
-18
-23
-25
-17
-18
-18
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
1
-1
-1
1
-36
-4
-4
0
-2
Pretax Income (Loss), Adjusted
-103
7
148
294
369
270
517
694
1,055
Abnormal Gains (Losses)
0
0
0
0
0
0
0
-350
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
-103
7
148
294
369
270
517
344
1,055
Income Tax (Expense) Benefit, net
34
1
-44
-82
-136
-104
-185
-393
-347
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-69
8
104
212
233
166
332
-49
709
Net Extraordinary Gains (Losses)
0
0
-5
1
0
0
0
0
0
Discontinued Operations
0
0
-5
1
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-69
8
99
212
233
166
332
-49
709
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
-69
8
99
212
233
166
332
-49
709
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-69
8
99
212
233
166
332
-49
709
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
229
627
403
479
694
696
954
1,051
Cash & Cash Equivalents
n/a
100
252
163
154
284
398
832
1,023
Short Term Investments
n/a
129
375
241
325
410
298
122
28
Accounts & Notes Receivable
n/a
51
74
89
117
126
162
193
215
Accounts Receivable, Net
n/a
51
74
89
117
126
162
193
215
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
26
36
46
37
48
67
81
100
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
18
28
24
35
46
33
47
60
Prepaid Expenses
n/a
8
9
10
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
7
13
8
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
3
7
6
35
46
33
47
60
Total Current Assets
n/a
325
764
562
668
914
958
1,275
1,425
Property, Plant & Equipment, Net
n/a
304
306
366
454
465
478
496
489
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
149
133
344
306
448
123
38
2
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
275
228
246
199
260
326
375
409
Intangible Assets
n/a
18
10
22
16
14
29
28
34
Goodwill
n/a
0
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
201
202
191
150
193
198
193
178
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
55
16
33
32
53
98
154
197
Total Noncurrent Assets
n/a
727
667
956
958
1,173
927
909
901
Total Assets
n/a
1,052
1,432
1,518
1,627
2,088
1,884
2,184
2,326
Liabilities and owners' equity
Payables & Accruals
n/a
30 29764000
50 50280000
57 57227000
83 83188000
92 92244000
85 85382000
103 103400000
104 104200000
Accounts Payable
n/a
30 29764000
50 50280000
57 57227000
83 83188000
92 92244000
85 85382000
103 103400000
104 104200000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
239 239022000
252 252114000
47 47257000
1 1291000
282 282459000
126 126414000
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
61 61401000
126 126292000
108 108093000
92 92276000
313 312971000
293 292514000
337 337300000
228 228300000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
61 61401000
126 126292000
108 108093000
92 92276000
313 312971000
293 292514000
337 337300000
228 228300000
Total Current Liabilities
n/a
330 330187000
429 428686000
213 212577000
177 176755000
688 687674000
504 504310000
441 440700000
333 332500000
Long Term Debt
n/a
0 0
69 68929000
266 265632000
275 275010000
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
68 68348000
50 50134000
91 91382000
91 90849000
141 140619000
138 137744000
155 155100000
142 141800000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
68 68348000
50 50134000
91 91382000
91 90849000
141 140619000
138 137744000
155 155100000
142 141800000
Total Noncurrent Liabilities
n/a
68 68348000
119 119063000
357 357014000
366 365859000
141 140619000
138 137744000
155 155100000
142 141800000
Total Liabilities
n/a
399 398535000
548 547749000
570 569591000
543 542614000
828 828293000
642 642054000
596 595800000
474 474300000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
799 799464000
929 929290000
993 993333000
1,016 1016456000
1,058 1057854000
1,377 1376801000
1,791 1791300000
1,814 1814200000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-67 -67395000
-67 -67399000
-283 -282998000
-471 -470998000
-513 -513437000
-1,186 -1185825000
-1,902 -1902100000
-2,380 -2379600000
Retained Earnings
n/a
-75 -74746000
31 31170000
249 249038000
553 553480000
728 728040000
1,068 1068114000
1,720 1719800000
2,434 2433500000
Other Equity
n/a
-4 -4314000
-9 -9175000
-11 -10885000
-15 -14957000
-13 -13183000
-17 -16734000
-20 -20400000
-17 -16800000
Equity Before Minority Interest
n/a
653 653009000
884 883886000
948 948488000
1,084 1083981000
1,259 1259274000
1,242 1242356000
1,589 1588600000
1,851 1851300000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
653 653009000
884 883886000
948 948488000
1,084 1083981000
1,259 1259274000
1,242 1242356000
1,589 1588600000
1,851 1851300000
Total Liabilities & Equity
n/a
1,052 1051544000
1,432 1431635000
1,518 1518079000
1,627 1626595000
2,088 2087567000
1,884 1884410000
2,184 2184400000
2,326 2325600000
Remarks restated on n/a restated on Feb 24, 2011 n/a restated on Feb 28, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 24, 2015 n/a restated on Feb 25, 2016 n/a restated on Feb 22, 2017 n/a restated on Apr 26, 2017 n/a
Cash Flow StatementCF data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-49
19
106
218
304
175
340
652
714
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
5
11
18
21
27
31
32
33
32
Non-Cash Items
-13
120
163
123
200
332
184
-100
16
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
18
-51
-75
-111
-208
-112
-201
-202
-117
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
-40
100
212
250
324
425
355
383
644
Change in Fixed Assets & Intangibles
-124
-95
-19
-36
-112
-32
-47
300
-43
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
7
-4
36
-4
0
-31
-45
-54
-36
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
-2
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-64
-64
-227
-82
-51
-232
431
258
130
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-181
-163
-209
-121
-163
-295
339
504
48
Dividends Paid
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
39
-1
-1
-1
-178
-133
-9
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
42
32
85
-188
-171
-16
-433
-355
-492
Increase in Capital Stock
42
32
85
24
17
27
50
39
8
Decrease in Capital Stock
0
0
0
-212
-188
-42
-483
-395
-500
Other Financing Activities
21
4
23
-29
3
12
34
41
3
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
63
36
147
-218
-169
-5
-577
-447
-498
Net Cash Before Disc. Operations and FX
-159
-26
149
-89
-9
125
117
439
194
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-159
-26
149
-89
-9
125
117
439
194
Effect of Foreign Exchange Rates
-1
-3
3
0
0
0
-4
-5
-3
Net Changes in Cash
-160
-29
152
-89
-9
125
113
434
191
Remarks
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo